Subcutaneous biopsy cavity marker device

US9456878B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9456878-B2
Application numberUS-77767110-A
CountryUS
Kind codeB2
Filing dateMay 11, 2010
Priority dateJun 6, 2003
Publication dateOct 4, 2016
Grant dateOct 4, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A marking device for identifying a subcutaneous biopsy cavity having a first nonabsorbable marker element detectable by a first imaging modality and a second nonabsorbable marker element detectable by a second imaging modality but not detectable by the first imaging modality.

First claim

Opening claim text (preview).

What is claimed is: 1. A breast biopsy marker comprising: a first marker element; a second marker element having an outer surface; the first marker element formed from a nonabsorbable metallic material detectable by an imaging means other than ultrasound; the second marker element formed from a nonabsorbable polymer detectable by ultrasound; and the first marker element is disposed around and contacts a portion of the outer surface of the second marker element. 2. The breast biopsy marker according to claim 1 , herein the first marker element is made from shaped-titanium. 3. The breast biopsy marker according to claim 1 , wherein the first marker element is detectable by magnetic resonance imaging. 4. The breast biopsy marker according to claim 1 , wherein the first marker element is radiopaque. 5. The breast biopsy marker according to claim 1 , wherein the second marker element is layered. 6. The breast biopsy marker according to claim 1 , wherein the second marker element is rolled. 7. The breast biopsy marker according to claim 1 , wherein the second marker element is a diecut polymer material. 8. A breast biopsy marker consisting of: a first marker element; a second marker element; the first marker element formed from a nonabsorbable metallic material detectable by an imaging means other than ultrasound; the second marker element formed from a nonabsorbable polymer detectable by ultrasound; and the first marker element is disposed around a portion of the second marker element. 9. The breast biopsy marker according to claim 8 , wherein the first marker element is made from shaped titanium. 10. The breast biopsy marker according to claim 8 , wherein, the first marker element is detectable by magnetic, resonance imaging. 11. The breast biopsy marker according to claim 8 wherein the first marker element is radiopaque. 12. The breast biopsy marker according to claim 8 , wherein the second marker element is layered. 13. The breast biopsy marker according to claim 8 wherein the second marker element is rolled. 14. The breast biopsy marker according to claim 8 , wherein the second marker element is a diecut polymer material. 15. The breast biopsy marker according to claim 8 , wherein the second marker has first and second ends, and wherein the first marker element is disposed around and contacts a portion of the outer surface spaced from the first and second ends. 16. The breast biopsy marker according to claim 1 , wherein the second marker has first and second ends, and wherein the first marker element is disposed around and contacts a portion of the outer surface spaced from the first and second ends. 17. The breast biopsy marker according to claim 8 , wherein the first marker element is a ring. 18. The breast biopsy marker according to claim 1 , wherein the first marker element is a ring. 19. The breast biopsy marker according to claim 12 , wherein the second marker element is fastened together by the first marker element. 20. The breast biopsy marker according to claim 13 , wherein the second marker element is secured together by the first marker element. 21. The breast biopsy marker according to claim 5 , wherein the second marker element is fastened together by the first marker element. 22. The breast biopsy marker according to claim 6 , wherein the second marker element is secured together by the first marker element.

Assignees

Inventors

Classifications

  • involving detecting or locating foreign bodies or organic structures · CPC title

  • ultrasonic · CPC title

  • magnetic, e.g. NMR or MRI · CPC title

  • Multi-modality markers · CPC title

  • Arrangements for detecting or locating foreign bodies · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9456878B2 cover?
A marking device for identifying a subcutaneous biopsy cavity having a first nonabsorbable marker element detectable by a first imaging modality and a second nonabsorbable marker element detectable by a second imaging modality but not detectable by the first imaging modality.
Who is the assignee on this patent?
Macfarlane K Angela, Zarins Sascha, Devicor Medical Products Inc
What technology area does this patent fall under?
Primary CPC classification A61B90/39. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).